This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

68Ga-PSMA-SR6

Advanced Accelerator Applications SA

Drug Names(s): 68Ga-PSMA-SR6

Description: 68Ga-PSMA-SR6 is in development as a companion diagnostic for prostate cancer through novel molecular nuclear medicine techniques.

Advanced Accelerator Applications plans to radiolabel PSMA-SR6 to develop a 177Lu-PSMA-SR6 to treat and monitor prostate cancer and a 68Ga-PSMA-SR6, which will help to diagnose and stage disease.

This is a companion diagnostic to be used with:
-177Lu-PSMA-SR6.


68Ga-PSMA-SR6 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug